Boiron

Boiron BOIRF Stock

$31.50   0.000000%
Add to favorites
Market Cap
$546.91M
LOW - HIGH [24H]
$31.50 - $31.50
VOLUME [24H]
$200.00
P/E Ratio
17.89
Earnings per share
$1.76
ISIN
FR0000061129
Price   Prediction

Boiron Price Chart

Sorry, that's all we've gotfor now...

Boiron BOIRF Financial and Trading Overview

Boiron stock price 31.5 USD
Previous Close 31.5 USD
Open 31.5 USD
Bid 29.25 USD x 10000
Ask 32.05 USD x 10000
Day's Range 31.5 - 31.5 USD
52 Week Range 24.5 - 32.28 USD
Volume 200 USD
Avg. Volume 3 USD
Market Cap 546.91M USD
Beta (5Y Monthly) 0.271
PE Ratio (TTM) 17.897728
EPS (TTM) 1.76 USD
Forward Dividend & Yield 1.57 (4.97%)
Ex-Dividend Date June 3, 2026
1y Target Est N/A

BOIRF Valuation Measures

Enterprise Value 520.05M USD
Trailing P/E 17.897728
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 1.1031317
Price/Book (mrq) 1.2944686
Enterprise Value/Revenue 1.049
Enterprise Value/EBITDA 9.172

Trading Information

Boiron Stock Price History

Beta (5Y Monthly) 0.271
52-Week Change 28.57%
S&P500 52-Week Change 14.57%
52 Week High 32.28 USD
52 Week Low 24.5 USD
50-Day Moving Average 31.5 USD
200-Day Moving Average 30.77 USD

BOIRF Share Statistics

Avg. Volume (3 month) 3 USD
Avg. Daily Volume (10-Days) 0 USD
Shares Outstanding 17.36M
Float 3.5M
Short Ratio N/A
% Held by Insiders 79.00%
% Held by Institutions 4.89%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 1.35
Trailing Annual Dividend Yield 4.28%
5 Year Average Dividend Yield 284.00%
Payout Ratio 0.894
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) June 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 5.28%
Operating Margin (ttm) 3.95%
Gross Margin 72.19%
EBITDA Margin 11.43%

Management Effectiveness

Return on Assets (ttm) 4.32%
Return on Equity (ttm) 7.03%

Income Statement

Revenue (ttm) 495.78M USD
Revenue Per Share (ttm) 28.56 USD
Quarterly Revenue Growth (yoy) -2.19%
Gross Profit (ttm) 357.94M USD
EBITDA 56.7M USD
Net Income Avi to Common (ttm) 26.19M USD
Diluted EPS (ttm) 1.76
Quarterly Earnings Growth (yoy) -56.79%

Balance Sheet

Total Cash (mrq) 50.67M USD
Total Cash Per Share (mrq) 2.92 USD
Total Debt (mrq) 23.8M USD
Total Debt/Equity (mrq) 6.34 USD
Current Ratio (mrq) 2.253
Book Value Per Share (mrq) 24.334309

Cash Flow Statement

Operating Cash Flow (ttm) 40.83M USD
Levered Free Cash Flow (ttm) 27.55M USD

Profile of Boiron

Country United States
State N/A
City Messimy
Address 2, avenue de l’Ouest Lyonnais
ZIP 69510
Phone 33 4 78 45 61 00
Website https://www.boiron.fr
Industry Drug Manufacturers - Specialty & Generic
Sector(s) Healthcare
Full Time Employees 2623

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers homeopathic medicines and homeopathic specialties; and other healthcare products, including medical devices (in vitro diagnostics), dietary supplements, herbal remedies, cosmetics, and CBD-based products. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; Sedative PC Granules to treat anxiety and emotional, and minor sleep disorders; Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; Homéovox for vocal disorders; Homéoplasmine for treating irritated skin and redness; Varésol to treat symptoms of chickenpox; and Arnicare Arthritis for use in the treatment of benign trauma pain. In addition, it offers Dermoplasmine, a plant based multi-use balm that repairs and protects irritated and damaged skin; COVID self-tests and rapid antigenic tests; LABIAMEO, that used to treat outbreaks of localized cold sores; and CONVAMEO to treat physical and mental asthenia. Further, the company provides Quietude, Rhinallergy, Ribes Nigrum Macerate Glycerin 1 DH Boiron, Sabal serrulata Mother Tincture Boiron, Sevameo, Sinupyl, Sportenine, Stodaline Sugar-Free, Stodal Granules, Stodal Syrup, Storinyl, Sedative PC Sublingual Tablet, Tilia Tomentosa Glycerinated Macerate 1DH Boiron, Varesol, Verrulia, Avenoc Suppository, Calendula Cream, Zelaceo, and Zenalia. It offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is based in Messimy, France.

Q&A For Boiron Stock

What is a current BOIRF stock price?

Boiron BOIRF stock price today per share is 31.5 USD.

How to purchase Boiron stock?

You can buy BOIRF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Boiron?

The stock symbol or ticker of Boiron is BOIRF.

Which industry does the Boiron company belong to?

The Boiron industry is Drug Manufacturers - Specialty & Generic.

How many shares does Boiron have in circulation?

The max supply of Boiron shares is 17.36M.

What is Boiron Price to Earnings Ratio (PE Ratio)?

Boiron PE Ratio is 17.89772800 now.

What was Boiron earnings per share over the trailing 12 months (TTM)?

Boiron EPS is 1.76 USD over the trailing 12 months.

Which sector does the Boiron company belong to?

The Boiron sector is Healthcare.

$2.92T
Total marketcap
$81.04B
Total volume
BTC 59.28%   •   ETH 11.35%
Dominance
Select currency